| scholarly article | Q13442814 |
| P6179 | Dimensions Publication ID | 1003073267 |
| P356 | DOI | 10.1038/CLPT.1984.190 |
| P698 | PubMed publication ID | 6467797 |
| P5875 | ResearchGate publication ID | 16728104 |
| P2093 | author name string | Bertilsson L | |
| Sjöqvist F | |||
| Hedman A | |||
| Mellström B | |||
| Adjepon-Yamoah KK | |||
| Woolhouse NM | |||
| P433 | issue | 3 | |
| P407 | language of work or name | English | Q1860 |
| P921 | main subject | Sweden | Q34 |
| P304 | page(s) | 374-378 | |
| P577 | publication date | 1984-09-01 | |
| P1433 | published in | Clinical Pharmacology & Therapeutics | Q1101529 |
| P1476 | title | Nortriptyline and debrisoquine hydroxylations in Ghanaian and Swedish subjects. | |
| P478 | volume | 36 |
| Q35004902 | 3,4-Dehydrodebrisoquine, a novel debrisoquine metabolite formed from 4-hydroxydebrisoquine that affects the CYP2D6 metabolic ratio |
| Q34209842 | Clinical pharmacokinetics of imipramine and desipramine |
| Q40602619 | Clinical trials and transethnic pharmacology |
| Q34448179 | Inter-subject and ethnic differences in paracetamol metabolism |
| Q52016009 | Interindividual Variations of Desmethylation and Hydroxylation of Amitriptyline in a Japanese Psychiatric Population |
| Q77831624 | Nortriptyline E-10-hydroxylation in vitro is mediated by human CYP2D6 (high affinity) and CYP3A4 (low affinity): implications for interactions with enzyme-inducing drugs |
| Q40730354 | Pharmacogenetic phenotyping and genotyping. Present status and future potential. |
| Q77495518 | Pharmacokinetics of nortriptyline and its 10-hydroxy metabolite in Chinese subjects of different CYP2D6 genotypes |
| Q41502209 | Plasma concentrations of nortriptyline and its 10-hydroxy metabolite in depressed patients--relationship to the debrisoquine hydroxylation metabolic ratio |
| Q71611376 | Population pharmacokinetics and pharmacodynamics: potential use for gathering dose-concentration-response |
| Q34346620 | Population pharmacokinetics of nortriptyline during monotherapy and during concomitant treatment with drugs that inhibit CYP2D6--an evaluation with the nonparametric maximum likelihood method |
| Q34448025 | Sparteine oxidation polymorphism in Greenlanders living in Denmark |
| Q60705943 | Steady-state concentrations of imipramine and its metabolites in relation to the sparteine/debrisoquine polymorphism |
| Q50544098 | Steady-state plasma levels of clomipramine and its metabolites: impact of the sparteine/debrisoquine oxidation polymorphism. Danish University Antidepressant Group. |
| Q57380871 | The Polymorphic Metabolism of Dextromethorphan |
| Q33924148 | The influence of ethnicity and antidepressant pharmacogenetics in the treatment of depression |
| Q47722116 | Time course of enzyme induction in humans: effect of pentobarbital on nortriptyline metabolism |
Search more.